Sermorelin, a 29 amino acid analog of human growth hormone-releasing hormone (GHRH), is the shortest synthetic peptide with a full biological activity of GHRH which is used as a diagnostic agent to assess growth hormone (GH) secretion for the purpose of diagnosing growth hormone deficiency. Intravenous and subcutaneous sermorelin specifically stimulate growth hormone secretion from the anterior pituitary. Sermorelin binds to the growth hormone releasing hormone receptor and mimics native GRF in its ability to stimulate growth hormone secretion. Hormone responses to intravenous sermorelin appear to be a rapid and relatively specific test for the diagnosis of growth hormone deficiency.
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/18031173
1 mcg/kg bodyweight
Route of Administration:
Intravenous
Substance Class |
Protein
Created
by
admin
on
Edited
Sat Dec 16 00:28:23 GMT 2023
by
admin
on
Sat Dec 16 00:28:23 GMT 2023
|
Protein Sub Type | |
Sequence Type | COMPLETE |
Record UNII |
89243S03TE
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-VATC |
QH01AC04
Created by
admin on Sat Dec 16 00:28:23 GMT 2023 , Edited by admin on Sat Dec 16 00:28:23 GMT 2023
|
||
|
WHO-ATC |
H01AC04
Created by
admin on Sat Dec 16 00:28:23 GMT 2023 , Edited by admin on Sat Dec 16 00:28:23 GMT 2023
|
||
|
NCI_THESAURUS |
C76358
Created by
admin on Sat Dec 16 00:28:23 GMT 2023 , Edited by admin on Sat Dec 16 00:28:23 GMT 2023
|
||
|
WHO-VATC |
QV04CD03
Created by
admin on Sat Dec 16 00:28:23 GMT 2023 , Edited by admin on Sat Dec 16 00:28:23 GMT 2023
|
||
|
WIKIPEDIA |
Designer-drugs-Sermorelin
Created by
admin on Sat Dec 16 00:28:23 GMT 2023 , Edited by admin on Sat Dec 16 00:28:23 GMT 2023
|
||
|
WHO-ATC |
V04CD03
Created by
admin on Sat Dec 16 00:28:23 GMT 2023 , Edited by admin on Sat Dec 16 00:28:23 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
89243S03TE
Created by
admin on Sat Dec 16 00:28:23 GMT 2023 , Edited by admin on Sat Dec 16 00:28:23 GMT 2023
|
PRIMARY | |||
|
DB00010
Created by
admin on Sat Dec 16 00:28:23 GMT 2023 , Edited by admin on Sat Dec 16 00:28:23 GMT 2023
|
PRIMARY | |||
|
2433
Created by
admin on Sat Dec 16 00:28:23 GMT 2023 , Edited by admin on Sat Dec 16 00:28:23 GMT 2023
|
PRIMARY | |||
|
86168-78-7
Created by
admin on Sat Dec 16 00:28:23 GMT 2023 , Edited by admin on Sat Dec 16 00:28:23 GMT 2023
|
PRIMARY | |||
|
DTXSID70903978
Created by
admin on Sat Dec 16 00:28:23 GMT 2023 , Edited by admin on Sat Dec 16 00:28:23 GMT 2023
|
PRIMARY | |||
|
9118
Created by
admin on Sat Dec 16 00:28:23 GMT 2023 , Edited by admin on Sat Dec 16 00:28:23 GMT 2023
|
PRIMARY | |||
|
C62088
Created by
admin on Sat Dec 16 00:28:23 GMT 2023 , Edited by admin on Sat Dec 16 00:28:23 GMT 2023
|
PRIMARY | |||
|
56188
Created by
admin on Sat Dec 16 00:28:23 GMT 2023 , Edited by admin on Sat Dec 16 00:28:23 GMT 2023
|
PRIMARY | RxNorm | ||
|
Sermorelin
Created by
admin on Sat Dec 16 00:28:23 GMT 2023 , Edited by admin on Sat Dec 16 00:28:23 GMT 2023
|
PRIMARY | |||
|
6998
Created by
admin on Sat Dec 16 00:28:23 GMT 2023 , Edited by admin on Sat Dec 16 00:28:23 GMT 2023
|
PRIMARY | |||
|
SUB10496MIG
Created by
admin on Sat Dec 16 00:28:23 GMT 2023 , Edited by admin on Sat Dec 16 00:28:23 GMT 2023
|
PRIMARY | |||
|
16132413
Created by
admin on Sat Dec 16 00:28:23 GMT 2023 , Edited by admin on Sat Dec 16 00:28:23 GMT 2023
|
PRIMARY | |||
|
6036
Created by
admin on Sat Dec 16 00:28:23 GMT 2023 , Edited by admin on Sat Dec 16 00:28:23 GMT 2023
|
PRIMARY | |||
|
m9870
Created by
admin on Sat Dec 16 00:28:23 GMT 2023 , Edited by admin on Sat Dec 16 00:28:23 GMT 2023
|
PRIMARY | Merck Index | ||
|
D017337
Created by
admin on Sat Dec 16 00:28:23 GMT 2023 , Edited by admin on Sat Dec 16 00:28:23 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
MOL_WEIGHT:SEQUENCE(CALCULATED) | CHEMICAL |
|
||||
Molecular Formula | CHEMICAL |
|